https://www.annalsthoracicsurgery.org/article/0003-4975(95)00537-U/pdf

Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer

Practice management guidelines for emergency department thoracotomy. Working Group, Ad Hoc Subcommittee on Outcomes, American College of Surgeons-Committee on Trauma.

PURPOSETo compare the accuracy of computed tomography-(CT) scan and the radiolabeled glucose analog 18F-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) visually correlated with CT (PET + CT) in the locoregional lymph node (LN) staging of non-small-cell lung cancer (NSCLC).PATIENTS AND METHODSSixty-eight patients with potentially operable NSCLC underwent thoracic CT, PET, and invasive surgical staging (ISS). Imaging studies were read prospectively and blinded to the surgical and pathologic data. A five-point visual scale was used for the interpretation of LNs on PET. Afterwards, with knowledge of the pathology, the relationship between standardized uptake values (SUVs) and the presence of metastasis in LNs was explored in a receiver operating characteristic (ROC) analysis, and the likelihood ratios (LRs) for SUVs of LNs were determined.RESULTSISS was available for 690 LN stations. CT correctly identified the nodal stage in 40 of 68 patients (59%), with understaging in 12 patients and over...

Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.

https://www.annalsthoracicsurgery.org/article/0003-4975(92)91040-G/pdf

Video-assisted thoracic surgery: Basic technical concepts and intercostal approach strategies

Background: The appropriate staging and treatment of patients with stage I and II non‐small-cell lung cancer (NSCLC) are important in that the potential for a lost curative opportunity in this population is greater than for those presenting with advanced NSCLC. Methods: Treatment options — surgery, radiation therapy, and chemotherapy — for stage I and II NSCLC are reviewed, and the impact of newer staging modalities on patient survival is discussed, including altering both the lead-time and clinicopathologic stage biases that exist in the diagnosis and treatment of NSCLC. Some predictions are also made regarding how that standard may change for clinicians in the near future, and methods for further improvements in posttreatment survival in this group are discussed. Results: Whenever possible, patients with early-stage NSCLC should be treated with surgical resection. Patients for whom resection is not an option may benefit from radiation as definitive therapy. Positive results with neoadjuvant chemotherapy have led to an ongoing randomized trial (Intergroup S9900) to compare surgery alone to neoadjuvant chemotherapy plus surgery. Conclusions: Staging bias may affect the overall low survival of early-stage NSCLC. However, true stage-specific survival may improve with newer imaging modalities. Future advances, including closed transthoracic radiation, thermal ablative therapy techniques, and gene therapy, may supplant the need to surgically resect these tumors to achieve local control.

Treatment of stage I and II non-small-cell lung cancer.

Diagnostic anterior mediastinotomy.

Comparison of lobectomy and wedge resection for carcinoma of the lung.

Palliative intubation in the management of esophageal carcinoma.

https://www.annalsthoracicsurgery.org/article/S0003-4975(10)63600-4/pdf

Herbert T. Ransdell

Papers

Diagnostic anterior mediastinotomy.

Comparison of lobectomy and wedge resection for carcinoma of the lung.

Palliative intubation in the management of esophageal carcinoma.

Management of Malignant Esophagorespiratory Fistula

Lye injuries of the esophagus. Analysis of ninety cases of lye ingestion.